DESIRAE DILLMAN: Open Payments
NPI 1720784614 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$374 in 24 payments from 7 companies in 2025. Trend: 2023 $124 · 2024 $569 · 2025 $374
Food & beverage: $365Education: $9
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 12 | $228 |
| Travere Therapeutics, Inc. | 7 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| SCPHARMACEUTICALS INC. | 1 | $22 |
| Calliditas Therapeutics US Inc. | 1 | $18 |
| AKEBIA THERAPEUTICS INC | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: VELPHORO, Kerendia, FUROSCIX, TARPEYO, Vafseo, Rybelsus, Filspari.
Industry payments across FL — which companies pay providers there.
